Following ELRIGs Drug Discovery Conference, News Medical took part in an insightful discussion with Dr. Andrew Buchanan, a renowned figure in the realm of biopharmaceutical research. Dr. Buchanan’s career spans 22 years, notably at Cambridge Antibody Technology, MedImmune, and AstraZeneca, where he has significantly contributed to the development of 18 antibody-based drugs, including three successful … Read more
In a recent article published in the journal Nature Reviews Neurology, researchers discuss the efficacy of tau-targeting Alzheimer’s disease (AD) therapies and strategies that can be implemented to improve these treatments, especially immunotherapies. Study: Tau-targeting therapies for Alzheimer disease: Current status and future directions. Image Credit: Gorodenkoff / Shutterstock.com Background Since 2018, the prevalence of AD has increased … Read more
The latest data on universal screening for type 1 diabetes (T1D) is reviewed in a session at this year’s Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 October). The talk will be given by Dr. Emily K. Sims, Associate Professor of Pediatrics, Center for Diabetes and Metabolic … Read more